M.F. Öksüz

A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients

G. Pamuk, F. Yıldız, U. Kalyoncu, 2016, Rheumatology International.

Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers.

A. Tufan, B. N. Coşkun, Y. Pehlivan, 2015, European journal of rheumatology.

Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.

A. Tufan, S. Ermurat, B. N. Coşkun, 2014, European journal of rheumatology.

The Evaluation of Amyloidosis Cases with Renal Involvement: A Single-Center Experience

M. Gullulu, A. Ersoy, A. Yildiz, 2015 .

SAT0582 Psoriasis Symptom Inventory is a Valid Patient-Reported Instrument for the Assessment of Skin Severityin Psoriatic Arthritis

D. Solmaz, A. Erden, F. Yıldız, 2015 .